AN2 Therapeutics, Inc. ANTX
4.00 USD +0.04 (+1.14%)
At closeNov 6, 2026, 4:00 PM EST
4.00 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
3.90 Day range 4.11
1.00 52-week range 7.19
- YTD
- +250.88%
- 1 year
- +257.14%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -38.11M | -56.79M | -69.64M | -42.26M | -21.61M | |
| -35.17M | -51.32M | -64.73M | -40.96M | -21.54M | |
| -1.16 | -1.72 | -2.74 | -2.79 | -10.64 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 19.94M | 21.35M | 15.65M | 27.22M | 12.10M | |
| 61.95M | 92.09M | 138.74M | 102.56M | 65.32M | |
| 8.89M | 10.24M | 14.04M | 7.19M | 3.41M | |
| 53.06M | 81.85M | 124.70M | 95.37M | -47.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -29.83M | -49.26M | -53.29M | -33.46M | -20.48M | |
| 28.31M | 54.59M | -43.28M | -21.77M | -50.02M | |
| 113.00K | 372.00K | 84.99M | 70.36M | 78.53M | |
| -1.41M | 5.70M | -11.57M | 15.12M | 8.03M |